Use your antibodies-online credentials, if available.
Keine Produkte auf Ihrer Vergleichsliste.
Ihr Warenkorb ist leer.
Alle Spezies anzeigen
Weitere Synonyme anzeigen
Wählen Sie die Spezies und Applikation aus
anti-Human Metabotropic Glutamate Receptor 3 Antikörper:
anti-Mouse (Murine) Metabotropic Glutamate Receptor 3 Antikörper:
anti-Rat (Rattus) Metabotropic Glutamate Receptor 3 Antikörper:
Sie gelangen zu unserer vorgefilterten Suche.
Results demonstrate that GRM3 expression is significantly upregulated in human colonic adenocarcinomas and colon cancer cell lines. This upregulation is mediated at the post-transcriptional level where miR (zeige MLXIP Antikörper)-487b directly targets GRM3 to suppress its translation. Also, the fact that TGFbeta (zeige TGFB1 Antikörper) increases GRM3 protein stability provide novel mechanisms of post-transcriptional regulation of GRM3 in colon cancer.
Low GRM3 expression is associated with multiple myeloma and B-cell leukemia.
Significant association was found between rs12704290 in GRM3 gene and schizophrenia(SCZ). A three-SNP LD spanning GRM3Delta4 splice site was significantly associated with SCZ. Interaction between the LD block and cognitive function was found in SCZ patients.
Results show that GRM3 rs274622 C carriers with schizophrenia were associated with significantly smaller prefrontal activation than patients with TT genotype
Grm3 expression was decreased in B cells from patients with autoimmune diseases such as activated systemic lupus erythematosus and multiple sclerosis.
Pharmacogenetic relationships were identified in patients with schizophrenia between GRM3 variants and symptom response to antipsychotics.
PI4KA (zeige PI4KA Antikörper) and GRM3 polymorphisms have potential to jointly modulate antipsychotic response
Findings suggest that mGluR2 (zeige GRM2 Antikörper)/3 and mGluR5s are unaltered in the anterior cingulate cortex in psychotic and nonpsychotic depression, bipolar disorder and schizophrenia
Results demonstrate no changes in expression and density of both 5-HT2AR and mGlu2 (zeige GRM2 Antikörper)/3R in the postmortem prefrontal cortex of subjects with major depressive disorder under basal conditions; antidepressant treatment induces a decrease in 5-HT2AR density
The mGluR3 promoted the proliferation of human embryonic cortical NPCs and increased cyclin D1 (zeige CCND1 Antikörper) expression by activating ERK1/2 (zeige MAPK1/3 Antikörper) and JNK2 (zeige MAPK9 Antikörper) signaling pathways.
the activation of mGluR3 up-regulates the membrane expression of TWIK-1 (zeige KCNK1 Antikörper) that in turn enhances NH4(+) uptake in astrocytes.
These studies provide a foundation for future research seeking to parse out the roles of mGlu2 (zeige GRM2 Antikörper) from mGlu3, paving the way for better understanding of how these receptors regulate activity in the brain.
provided evidence that JARID1B (zeige KDM5B Antikörper) via modulation of stemness-related signaling is a putative novel therapeutic target for treating malignant NB
Activation of GABA(B) or mGlu2 (zeige GRM2 Antikörper)/3 receptors inhibited both evoked presynaptic Ca(2 (zeige CA2 Antikörper)+) transients and striatal field potentials.
Activation of Grm3 ameliorates lupus-like disease in mice by reducing B cell numbers. Grm3 expression on B-cells is decreased in lupus-prone mice.
The number of mGluR3-immunoractive cells was significantly reduced in the dorsal and intermediate but not ventral parts of the lateral septum in postpartum versus virgin females.
GRM3-knockout mice exhibit a biphasic effect in spatial working memory, initially impaired but performing better after training.
The results of these studies implicate mGlu3 as a major regulator of PFC (zeige CFP Antikörper) function and cognition.
This study demonistrated that mGluR3 knockout mice show a working memory defect.
report we describe a novel neuroprotective function of mGlu3 receptors related to their ability to promote the non-amyloidogenic pathway of APP (zeige APP Antikörper) cleavage in astrocytes, thus enhancing sAPPalpha production
L-glutamate is the major excitatory neurotransmitter in the central nervous system and activates both ionotropic and metabotropic glutamate receptors. Glutamatergic neurotransmission is involved in most aspects of normal brain function and can be perturbed in many neuropathologic conditions. The metabotropic glutamate receptors are a family of G protein-coupled receptors, that have been divided into 3 groups on the basis of sequence homology, putative signal transduction mechanisms, and pharmacologic properties. Group I includes GRM1 and GRM5 and these receptors have been shown to activate phospholipase C. Group II includes GRM2 and GRM3 while Group III includes GRM4, GRM6, GRM7 and GRM8. Group II and III receptors are linked to the inhibition of the cyclic AMP cascade but differ in their agonist selectivities.
metabotropic glutamate receptor 3
, glutamate metabotropic receptor 3
, G protein-coupled receptor, family C, group 1, member C